{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:27:22Z","timestamp":1794536842979,"version":"4.9.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["W030489\/1"],"award-info":[{"award-number":["W030489\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Humoral immunity proteins\u2014immunoglobulins, complement proteins, and antimicrobial peptides\u2014have key antimicrobial and immunomodulatory functions in sepsis. We hypothesised that their circulating levels are lower in non-survivors, potentially resulting in impaired bacterial clearance and persistent or recurrent infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review and meta-analysis evaluating differences in humoral immunity proteins between survivors and non-survivors in adult patients with sepsis. PubMed and Embase were searched without date restrictions. Random-effects meta-analyses were used to estimate pooled standardised mean differences (SMD) with 95% confidence intervals (CI). Sensitivity analyses included data from the MIMIC-IV ICU database, and further supplemented by three proteomic studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-six studies including 6,330 patients were analysed. Thirteen reported on immunoglobulins, 17 on complement proteins, and 7 on the antimicrobial peptide heparin-binding protein (HBP). Survivors had significantly higher levels of complement proteins C3 (SMD 0.53 [0.07\u20130.99]) and C4 (SMD 0.51 [0.09\u20130.94]) compared to non-survivors. Conversely, C4a (SMD \u2212\u20091.17 [\u20131.77 to \u2212\u20090.56]) and IgA (SMD \u2212\u20090.21 [\u20130.39 to \u2212\u20090.03]) were significantly lower in survivors. No differences were found for IgG (SMD 0.00 [\u20130.18 to 0.18]), IgM (SMD \u2212\u20090.02 [\u20130.13 to 0.08]), C5, C5a, or HBP. Sensitivity analyses using MIMIC-IV (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092,452) and proteomic datasets supported these findings. Proteomic data revealed early depletion of classical complement components (C3, C4B) and regulatory proteins in non-survivors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sepsis non-survivors exhibit lower C3 and C4 levels and higher C4a, consistent with complement activation and\/or depletion. Complement proteins may serve as potential biomarkers and therapeutic targets in sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-025-05758-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:25:18Z","timestamp":1766435118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsis"],"prefix":"10.1186","volume":"30","author":[{"given":"Antoine","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Pisciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Kerneis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl","family":"Batum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hilpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"de Nooijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Hedetoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas F.","family":"Bermejo-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina C.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Meessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu Hsuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Caironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari C.","family":"de la Torre Terr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ebelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Bodelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Tverring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merry L.","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Kingsmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Brealey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2222-3180","authenticated-orcid":false,"given":"Nishkantha","family":"Arulkumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"5758_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"5758_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"5758_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374. https:\/\/doi.org\/10.1038\/nri3552.","journal-title":"Nat Rev Immunol"},{"key":"5758_CR4","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19:e422\u201336. https:\/\/doi.org\/10.1016\/S1473-3099(19)30567-5.","journal-title":"Lancet Infect Dis"},{"key":"5758_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"G Mantovani Alberto","year":"2023","unstructured":"Mantovani Alberto G. Humoral innate immunity and acute-phase proteins. N Engl J Med. 2023;388:439\u201352. https:\/\/doi.org\/10.1056\/NEJMra2206346.","journal-title":"N Engl J Med"},{"key":"5758_CR6","first-page":"289","volume":"21 3","author":"D Tichaczek-Goska","year":"2012","unstructured":"Tichaczek-Goska D, Witkowska D, Cisowska A, et al. The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan. Advances in clinical and experimental medicine: official organ. Wroclaw Med Univ. 2012;21 3:289\u201399.","journal-title":"Wroclaw Med Univ"},{"key":"5758_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2460\/ajvr.1976.37.04.389","volume":"37","author":"C Ej","year":"1976","unstructured":"Ej C, Gl C. Bactericidal activity of bovine neonatal serums for selected coliform bacteria in relation to total protein and immunoglobulin G1 and immunoglobulin M concentrations. Am J Vet Res. 1976;37:389\u201394.","journal-title":"Am J Vet Res"},{"key":"5758_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1128\/iai.27.3.784-792.1980","volume":"27","author":"RW Tofte","year":"1980","unstructured":"Tofte RW, Peterson PK, Schmeling D, et al. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infect Immun. 1980;27:784\u201392. https:\/\/doi.org\/10.1128\/iai.27.3.784-792.1980.","journal-title":"Infect Immun"},{"key":"5758_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.582779","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H. Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.582779.","journal-title":"Front Microbiol"},{"key":"5758_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10:1. https:\/\/doi.org\/10.1038\/s41597-022-01899-x.","journal-title":"Sci Data"},{"key":"5758_CR11","unstructured":"Wells G, Shea B, O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis."},{"key":"5758_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh0185","volume":"16","author":"Y Mi","year":"2024","unstructured":"Mi Y, Burnham KL, Charles PD, et al. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response. Sci Transl Med. 2024;16:eadh0185. https:\/\/doi.org\/10.1126\/scitranslmed.adh0185.","journal-title":"Sci Transl Med"},{"key":"5758_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001134","volume":"43","author":"A DeCoux","year":"2015","unstructured":"DeCoux A, Tian Y, DeLeon-Pennell KY, et al. Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways*. Crit Care Med. 2015;43:2049. https:\/\/doi.org\/10.1097\/CCM.0000000000001134.","journal-title":"Crit Care Med"},{"key":"5758_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005893","volume":"5","author":"RJ Langley","year":"2013","unstructured":"Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra95-195ra95. https:\/\/doi.org\/10.1126\/scitranslmed.3005893.","journal-title":"Sci Transl Med"},{"key":"5758_CR15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.938538","volume":"29","author":"H Xue","year":"2023","unstructured":"Xue H, Yu F. Changes in heparin-binding protein, procalcitonin, and C-reactive protein within the first 72 hours predict 28-day mortality in patients admitted to the intensive care unit with septic shock. Med Sci Monit. 2023;29:e938538. https:\/\/doi.org\/10.12659\/MSM.938538.","journal-title":"Med Sci Monit"},{"key":"5758_CR16","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2147\/IJGM.S409328","volume":"16","author":"J Tang","year":"2023","unstructured":"Tang J, Yuan H, Wu YL, et al. The predictive value of heparin-binding protein and D-dimer in patients with sepsis. Int J Gen Med. 2023;16:2295\u2013303. https:\/\/doi.org\/10.2147\/IJGM.S409328.","journal-title":"Int J Gen Med"},{"key":"5758_CR17","doi-asserted-by":"publisher","first-page":"10751","DOI":"10.1038\/s41598-022-14827-1","volume":"12","author":"Q-L Dou","year":"2022","unstructured":"Dou Q-L, Liu J, Zhang W, et al. Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit. Sci Rep. 2022;12:10751. https:\/\/doi.org\/10.1038\/s41598-022-14827-1.","journal-title":"Sci Rep"},{"key":"5758_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/SHK.0000000000001900","volume":"57","author":"K Katsaros","year":"2022","unstructured":"Katsaros K, Renieris G, Safarika A, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study. Shock. 2022;57:518\u201325. https:\/\/doi.org\/10.1097\/SHK.0000000000001900.","journal-title":"Shock"},{"key":"5758_CR19","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.3390\/jcm10225391","volume":"10","author":"N Pathare","year":"2021","unstructured":"Pathare N, Szakmany T, Hall JE, Heurich M. Plasma IgM levels differentiate between survivors and non-survivors of culture-positive and culture-negative sepsis and SIRS: a pilot study. J Clin Med. 2021;10:5391. https:\/\/doi.org\/10.3390\/jcm10225391.","journal-title":"J Clin Med"},{"key":"5758_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jcrc.2012.08.004","volume":"27","author":"E Tamayo","year":"2012","unstructured":"Tamayo E, Fern\u00e1ndez A, Almansa R, et al. Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock. J Crit Care. 2012;27:616\u201322. https:\/\/doi.org\/10.1016\/j.jcrc.2012.08.004.","journal-title":"J Crit Care"},{"key":"5758_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jmii.2020.08.013","volume":"54","author":"M Akatsuka","year":"2021","unstructured":"Akatsuka M, Tatsumi H, Sonoda T, Masuda Y. Low immunoglobulin G level is associated with poor outcomes in patients with sepsis and septic shock. J Microbiol Immunol Infect. 2021;54:728\u201332. https:\/\/doi.org\/10.1016\/j.jmii.2020.08.013.","journal-title":"J Microbiol Immunol Infect"},{"key":"5758_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13613-021-00952-z","volume":"11","author":"L Alagna","year":"2021","unstructured":"Alagna L, Meessen JMTA, Bellani G, et al. Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the albumin Italian outcome sepsis (ALBIOS) trial. Ann Intensive Care. 2021;11:161. https:\/\/doi.org\/10.1186\/s13613-021-00952-z.","journal-title":"Ann Intensive Care"},{"key":"5758_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00063-015-0121-0","volume":"112","author":"C Geier","year":"2017","unstructured":"Geier C, Schr\u00f6der J, Tamm A, et al. Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients. Med Klin Intensivmed Notfmed. 2017;112:30\u20137. https:\/\/doi.org\/10.1007\/s00063-015-0121-0.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"5758_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/SHK.0000000000001502","volume":"54","author":"TH Cheng","year":"2020","unstructured":"Cheng TH, Puskarich M, Li X, et al. Circulating complement C3-Alpha chain levels predict survival of septic shock patients. Shock. 2020;54:190\u20137. https:\/\/doi.org\/10.1097\/SHK.0000000000001502.","journal-title":"Shock"},{"key":"5758_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000128478","volume":"17","author":"R Dionigi","year":"2008","unstructured":"Dionigi R, Dominioni L, Jemos V, et al. Sepsis score and complement factor B for monitoring severely septic surgical patients and for predicting their survival. Eur Surg Res. 2008;17:269\u201380. https:\/\/doi.org\/10.1159\/000128478.","journal-title":"Eur Surg Res"},{"key":"5758_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/JIR.S344282","volume":"15","author":"FM Ahmad","year":"2022","unstructured":"Ahmad FM, Al-Binni MA, Hani AB, et al. Complement terminal pathway activation is associated with organ failure in sepsis patients. JIR. 2022;15:153\u201362. https:\/\/doi.org\/10.2147\/JIR.S344282.","journal-title":"JIR"},{"key":"5758_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000520496","volume":"14","author":"M Hedetoft","year":"2022","unstructured":"Hedetoft M, Madsen MB, Hansen CB, et al. Increase in the complement activation product C4d and the terminal complement complex sC5b-9 is associated with disease severity and a fatal outcome in necrotizing soft-tissue infection. J Innate Immun. 2022;14:355\u201365. https:\/\/doi.org\/10.1159\/000520496.","journal-title":"J Innate Immun"},{"key":"5758_CR28","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1097\/CCM.0000000000001265","volume":"43","author":"A Linder","year":"2015","unstructured":"Linder A, Arnold R, Boyd JH, et al. Heparin-Binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department. Crit Care Med. 2015;43:2378\u201386. https:\/\/doi.org\/10.1097\/CCM.0000000000001265.","journal-title":"Crit Care Med"},{"key":"5758_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc5694","volume":"11","author":"M Book","year":"2007","unstructured":"Book M, Chen Q, Lehmann LE, et al. Inducibility of the endogenous antibiotic peptide \u03b2-defensin 2 is impaired in patients with severe sepsis. Crit Care. 2007;11:1\u20138. https:\/\/doi.org\/10.1186\/cc5694.","journal-title":"Crit Care"},{"key":"5758_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s001340000616","volume":"26","author":"E Rintala","year":"2000","unstructured":"Rintala E, Peuravuori H, Pulkki K, et al. Bactericidal\/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome. Intensive Care Med. 2000;26:1248\u201351. https:\/\/doi.org\/10.1007\/s001340000616.","journal-title":"Intensive Care Med"},{"key":"5758_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11353","volume":"16","author":"A Linder","year":"2012","unstructured":"Linder A, \u00c5kesson P, Inghammar M, et al. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care. 2012;16:1\u201311. https:\/\/doi.org\/10.1186\/cc11353.","journal-title":"Crit Care"},{"key":"5758_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00063-016-0220-6","volume":"112","author":"S Dietz","year":"2017","unstructured":"Dietz S, Lautenschl\u00e4ger C, M\u00fcller-Werdan U, et al. Serum IgG levels and mortality in patients with severe sepsis and septic shock. Med Klin Intensivmed Notfmed. 2017;112:462\u201370. https:\/\/doi.org\/10.1007\/s00063-016-0220-6.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"5758_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jcrc.2018.01.010","volume":"45","author":"X-W Liu","year":"2018","unstructured":"Liu X-W, Ma T, Liu W, et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis. J Crit Care. 2018;45:14\u20139. https:\/\/doi.org\/10.1016\/j.jcrc.2018.01.010.","journal-title":"J Crit Care"},{"key":"5758_CR34","doi-asserted-by":"publisher","first-page":"e0152035","DOI":"10.1371\/journal.pone.0152035","volume":"11","author":"J Tyd\u00e9n","year":"2016","unstructured":"Tyd\u00e9n J, Herwald H, Sj\u00f6berg F, Johansson J. Increased plasma levels of Heparin-Binding protein on admission to intensive care are associated with respiratory and circulatory failure. PLoS One. 2016;11:e0152035. https:\/\/doi.org\/10.1371\/journal.pone.0152035.","journal-title":"PLoS One"},{"key":"5758_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00011-011-0422-6","volume":"61","author":"MS Chew","year":"2012","unstructured":"Chew MS, Linder A, Santen S, et al. Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort study. Inflamm Res. 2012;61:375\u20139. https:\/\/doi.org\/10.1007\/s00011-011-0422-6.","journal-title":"Inflamm Res"},{"key":"5758_CR36","doi-asserted-by":"publisher","first-page":"e026527","DOI":"10.1136\/bmjopen-2018-026527","volume":"9","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Liu Z, Huang J, et al. Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China. BMJ Open. 2019;9:e026527. https:\/\/doi.org\/10.1136\/bmjopen-2018-026527.","journal-title":"BMJ Open"},{"key":"5758_CR37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.21608\/ejhm.2021.165497","volume":"83","author":"MLM Elsayed","year":"2021","unstructured":"Elsayed MLM, El-Wakel SA, Hamid MA, et al. Heparin binding protein as a predictive marker for sepsis and septic shock in critically ill patients: a cross sectional study. Egypt J Hosp Med. 2021;83:1290\u20136. https:\/\/doi.org\/10.21608\/ejhm.2021.165497.","journal-title":"Egypt J Hosp Med"},{"key":"5758_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4103\/1110-1415.198657","volume":"44","author":"H Ibrahim","year":"2016","unstructured":"Ibrahim H, Ragab M, Rizk F, et al. Role of heparin-binding protein and brachial artery reactivity as prognostic tests in critically ill patients with sepsis. Tanta Med J. 2016;44:107. https:\/\/doi.org\/10.4103\/1110-1415.198657.","journal-title":"Tanta Med J"},{"key":"5758_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/605563","volume":"49","author":"A Linder","year":"2009","unstructured":"Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009;49:1044\u201350. https:\/\/doi.org\/10.1086\/605563.","journal-title":"Clin Infect Dis"},{"key":"5758_CR40","doi-asserted-by":"publisher","first-page":"1126874","DOI":"10.3389\/fimmu.2023.1126874","volume":"14","author":"H Tang","year":"2023","unstructured":"Tang H, Qin S, Li Z, et al. Early immune system alterations in patients with septic shock. Front Immunol. 2023;14:1126874. https:\/\/doi.org\/10.3389\/fimmu.2023.1126874.","journal-title":"Front Immunol"},{"key":"5758_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.14712\/23362936.2014.14","volume":"114","author":"M Pr\u016fcha","year":"2013","unstructured":"Pr\u016fcha M, Pr\u016fcha M, Roman Z, et al. Presence of hypogammaglobulinemia - a risk factor of mortality in patients with severe sepsis, septic shock, and SIRS. Prague Med Rep. 2013;114:246\u201357. https:\/\/doi.org\/10.14712\/23362936.2014.14.","journal-title":"Prague Med Rep"},{"key":"5758_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jinf.2013.11.003","volume":"68","author":"M Prucha","year":"2014","unstructured":"Prucha M, Zazula R, Herold I, et al. Presence of hypogammaglobulinemia in patients with severe sepsis, septic shock, and SIRS is associated with increased mortality. J Infect. 2014;68:297\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2013.11.003.","journal-title":"J Infect"},{"key":"5758_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","volume":"32","author":"FS Taccone","year":"2009","unstructured":"Taccone FS, Stordeur P, De Backer D, et al. Gamma-globulin levels in patients with community-acquired septic shock. Shock. 2009;32:379\u201385. https:\/\/doi.org\/10.1097\/SHK.0b013e3181a2c0b2.","journal-title":"Shock"},{"key":"5758_CR44","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1097\/00003246-200712000-00026","volume":"35","author":"K Werdan","year":"2007","unstructured":"Werdan K, Pilz G, Bujdoso O, et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med. 2007;35:2693\u2013701.","journal-title":"Crit Care Med"},{"key":"5758_CR45","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1097\/SHK.0000000000001332","volume":"52","author":"F Kahn","year":"2019","unstructured":"Kahn F, Tverring J, Mellhammar L, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department. Shock. 2019;52:e135\u201345. https:\/\/doi.org\/10.1097\/SHK.0000000000001332.","journal-title":"Shock"},{"key":"5758_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/01.shk.0000370606.30525.21","volume":"33","author":"PM Myrianthefs","year":"2010","unstructured":"Myrianthefs PM, Boutzouka E, Baltopoulos GJ. \u0393-globulin levels in patients with community-acquired septic shock. Shock. 2010;33:556. https:\/\/doi.org\/10.1097\/01.shk.0000370606.30525.21.","journal-title":"Shock"},{"key":"5758_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-023-04344-6","volume":"27","author":"AH de Nooijer","year":"2023","unstructured":"de Nooijer AH, Kotsaki A, Kranidioti E, et al. Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity. Crit Care. 2023;27:1\u20136. https:\/\/doi.org\/10.1186\/s13054-023-04344-6.","journal-title":"Crit Care"},{"key":"5758_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00311579","volume":"26","author":"H Nakae","year":"1996","unstructured":"Nakae H, Endo S, Inada K, Yoshida M. Chronological changes in the complement system in sepsis. Surg Today. 1996;26:225\u20139. https:\/\/doi.org\/10.1007\/BF00311579.","journal-title":"Surg Today"},{"key":"5758_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/cdli.3.2.175-183.1996","volume":"3","author":"S St\u00f6ve","year":"1996","unstructured":"St\u00f6ve S, Welte T, Wagner TO, et al. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol. 1996;3:175\u201383.","journal-title":"Clin Diagn Lab Immunol"},{"key":"5758_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archsurg.1992.01420100077014","volume":"127","author":"M Gardinali","year":"1992","unstructured":"Gardinali M, Padalino P, Vesconi S, et al. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis: correlation with severity of disease. Arch Surg. 1992;127:1219\u201324. https:\/\/doi.org\/10.1001\/archsurg.1992.01420100077014.","journal-title":"Arch Surg"},{"key":"5758_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","volume":"86","author":"CE Hack","year":"1989","unstructured":"Hack CE, Nuijens JH, Felt-Bersma RJF, et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med. 1989;86:20\u20136. https:\/\/doi.org\/10.1016\/0002-9343(89)90224-6.","journal-title":"Am J Med"},{"key":"5758_CR52","doi-asserted-by":"publisher","first-page":"e36724","DOI":"10.1097\/MD.0000000000036724","volume":"102","author":"T Chen","year":"2023","unstructured":"Chen T, Liu Y, Tang Y, et al. Use of cardiac troponin I, lactic acid, procalcitonin, and serum complement C3 as prognostic indicators in patients with sepsis. Med. 2023;102:e36724. https:\/\/doi.org\/10.1097\/MD.0000000000036724.","journal-title":"Med"},{"key":"5758_CR53","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.2147\/JIR.S322391","volume":"14","author":"H Li","year":"2021","unstructured":"Li H, Chen J, Hu Y, et al. Serum C1q levels have prognostic value for sepsis and are related to the severity of sepsis and organ damage. J Inflamm Res. 2021;14:4589\u2013600. https:\/\/doi.org\/10.2147\/JIR.S322391.","journal-title":"J Inflamm Res"},{"key":"5758_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM197301042880105","volume":"288","author":"WR McCabe","year":"1973","unstructured":"McCabe WR. Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med. 1973;288:21\u20133. https:\/\/doi.org\/10.1056\/NEJM197301042880105.","journal-title":"N Engl J Med"},{"key":"5758_CR55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2217\/bmm.15.32","volume":"9","author":"X Zhao","year":"2015","unstructured":"Zhao X, Chen Y-X, Li C-S. The prognostic performance of the complement system in septic patients in emergency department: a cohort study. Biomark Med. 2015;9:661\u20138. https:\/\/doi.org\/10.2217\/bmm.15.32.","journal-title":"Biomark Med"},{"key":"5758_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00408-017-0067-5","volume":"196","author":"E Zogheib","year":"2018","unstructured":"Zogheib E, Nyga R, Cornu M, et al. Prospective observational study on the association between serum Mannose-Binding lectin levels and severe outcome in critically ill patients with pandemic influenza type A (H1N1) infection. Lung. 2018;196:65\u201372. https:\/\/doi.org\/10.1007\/s00408-017-0067-5.","journal-title":"Lung"},{"key":"5758_CR57","doi-asserted-by":"publisher","first-page":"R243","DOI":"10.1186\/cc10501","volume":"15","author":"D Andaluz-Ojeda","year":"2011","unstructured":"Andaluz-Ojeda D, Iglesias V, Bobillo F, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care. 2011;15:R243. https:\/\/doi.org\/10.1186\/cc10501.","journal-title":"Crit Care"},{"key":"5758_CR58","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijid.2008.03.009","volume":"12","author":"ABJ Groeneveld","year":"2008","unstructured":"Groeneveld ABJ, Hack CE. The role of the innate immune response in hospital- versus community-acquired infection in febrile medical patients. Int J Infect Dis. 2008;12:660\u201370. https:\/\/doi.org\/10.1016\/j.ijid.2008.03.009.","journal-title":"Int J Infect Dis"},{"key":"5758_CR59","doi-asserted-by":"publisher","unstructured":"Dionigi, R et al. \u201cSepsis score and complement factor B for monitoring severely septic surgical patients and for predicting their survival.\u201d European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes vol. 17,5 (1985): 269-80. https:\/\/doi.org\/10.1159\/00012847","DOI":"10.1159\/00012847"},{"key":"5758_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joim.12265","volume":"276","author":"JF Bermejo-Mart\u00edn","year":"2014","unstructured":"Bermejo-Mart\u00edn JF, Rodriguez-Fernandez A, Herr\u00e1n-Monge R, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276:404\u201312. https:\/\/doi.org\/10.1111\/joim.12265.","journal-title":"J Intern Med"},{"key":"5758_CR61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","volume":"44","author":"T Welte","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med. 2018;44:438\u201348. https:\/\/doi.org\/10.1007\/s00134-018-5143-7.","journal-title":"Intensive Care Med"},{"key":"5758_CR62","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","volume":"11","author":"F Venet","year":"2011","unstructured":"Venet F, Gebeile R, Bancel J, et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol. 2011;11:2086\u201390. https:\/\/doi.org\/10.1016\/j.intimp.2011.08.024.","journal-title":"Int Immunopharmacol"},{"key":"5758_CR63","doi-asserted-by":"publisher","first-page":"e12642","DOI":"10.1016\/j.heliyon.2022.e12642","volume":"8","author":"F Zhang","year":"2022","unstructured":"Zhang F, Wan T, Liu X, Guo S. Prediction of short-term mortality in elderly patients with sepsis using Immunoglobulin G2: an observational study. Heliyon. 2022;8:e12642. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12642.","journal-title":"Heliyon"},{"key":"5758_CR64","doi-asserted-by":"publisher","first-page":"R247","DOI":"10.1186\/cc13073","volume":"17","author":"EJ Giamarellos-Bourboulis","year":"2013","unstructured":"Giamarellos-Bourboulis EJ, Apostolidou E, Lada M, et al. Kinetics of circulating Immunoglobulin M in sepsis: relationship with final outcome. Crit Care. 2013;17:R247. https:\/\/doi.org\/10.1186\/cc13073.","journal-title":"Crit Care"},{"key":"5758_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2016-000152","volume":"3","author":"MC de la Torre","year":"2016","unstructured":"de la Torre MC, Tor\u00e1n P, Serra-Prat M, et al. Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ Open Respir Res. 2016;3:e000152. https:\/\/doi.org\/10.1136\/bmjresp-2016-000152.","journal-title":"BMJ Open Respir Res"},{"key":"5758_CR66","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s13054-024-05197-3","volume":"28","author":"E Rademaker","year":"2024","unstructured":"Rademaker E, Vernooij LM, van der Poll T, et al. Longitudinal assessment of Immunoglobulin response and disease progression in critically ill patients with community acquired pneumonia. Crit Care. 2024;28:405. https:\/\/doi.org\/10.1186\/s13054-024-05197-3.","journal-title":"Crit Care"},{"key":"5758_CR67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000317036","volume":"2","author":"I Berkestedt","year":"2010","unstructured":"Berkestedt I, Herwald H, Ljunggren L, et al. Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsis. J Innate Immun. 2010;2:478\u201382. https:\/\/doi.org\/10.1159\/000317036.","journal-title":"J Innate Immun"},{"key":"5758_CR68","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.1038\/s41598-020-72003-9","volume":"10","author":"M Bergquist","year":"2020","unstructured":"Bergquist M, Samuelsson L, Larsson A, et al. TNFR1, TNFR2, neutrophil gelatinase-associated Lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort. Sci Rep. 2020;10:15350. https:\/\/doi.org\/10.1038\/s41598-020-72003-9.","journal-title":"Sci Rep"},{"key":"5758_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13613-017-0330-1","volume":"7","author":"J Tverring","year":"2017","unstructured":"Tverring J, Vaara ST, Fisher J, et al. Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury. Ann Intensive Care. 2017;7:105. https:\/\/doi.org\/10.1186\/s13613-017-0330-1.","journal-title":"Ann Intensive Care"},{"key":"5758_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07611-4","author":"E Azoulay","year":"2024","unstructured":"Azoulay E, Zuber J, AA Bousfiha, et al. Complement system activation: bridging physiology, pathophysiology, and therapy. Intensive Care Med. 2024. https:\/\/doi.org\/10.1007\/s00134-024-07611-4.","journal-title":"Intensive Care Med"},{"key":"5758_CR71","first-page":"127","volume":"63","author":"DJ Barrett","year":"1986","unstructured":"Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to Pneumococcal polysaccharides. Clin Exp Immunol. 1986;63:127\u201334.","journal-title":"Clin Exp Immunol"},{"key":"5758_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2249.1990.tb05339.x","volume":"81","author":"R Jefferis","year":"1990","unstructured":"Jefferis R, Kumararatne DS. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990;81:357\u201367. https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05339.x.","journal-title":"Clin Exp Immunol"},{"key":"5758_CR73","doi-asserted-by":"publisher","first-page":"595535","DOI":"10.3389\/fimmu.2020.595535","volume":"11","author":"K Jones","year":"2020","unstructured":"Jones K, Savulescu AF, Brombacher F, Hadebe S. Immunoglobulin M in health and diseases: how far have we come and what next? Front Immunol. 2020;11:595535. https:\/\/doi.org\/10.3389\/fimmu.2020.595535.","journal-title":"Front Immunol"},{"key":"5758_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12967-023-04592-8","volume":"21","author":"B Pan","year":"2023","unstructured":"Pan B, Sun P, Pei R, et al. Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis. J Transl Med. 2023;21:765. https:\/\/doi.org\/10.1186\/s12967-023-04592-8.","journal-title":"J Transl Med"},{"key":"5758_CR75","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13054-023-04719-9","volume":"27","author":"M Singer","year":"2023","unstructured":"Singer M, Torres A, Heinz CC, et al. The immunomodulating activity of Trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial. Crit Care. 2023;27:436. https:\/\/doi.org\/10.1186\/s13054-023-04719-9.","journal-title":"Crit Care"},{"key":"5758_CR76","first-page":"112","volume":"11 2","author":"S Ati\u015f","year":"2001","unstructured":"Ati\u015f S, Tutluo\u011flu B, Salep\u00e7i B, Ocal Z. Serum IgA and secretory IgA levels in bronchial lavages from patients with a variety of respiratory diseases. J Investigat Allergol Clin Immunol. 2001;11 2:112\u20137.","journal-title":"J Investigat Allergol Clin Immunol"},{"key":"5758_CR77","unstructured":"IgA subclasses have different. effector functions associated with distinct glycosylation profiles | Nature Communications. https:\/\/www-nature-com.ezproxy.u-paris.fr\/articles\/s41467-019-13992-8. Accessed 23 Jan 2025."},{"key":"5758_CR78","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0140-6736(00)02712-4","volume":"356","author":"M Levin","year":"2000","unstructured":"Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal\/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet. 2000;356:961\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(00)02712-4.","journal-title":"Lancet"},{"key":"5758_CR79","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"key":"5758_CR80","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to Steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199:980\u20136. https:\/\/doi.org\/10.1164\/rccm.201807-1419OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"5758_CR81","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5:816\u201326. https:\/\/doi.org\/10.1016\/S2213-2600(17)30294-1.","journal-title":"Lancet Respir Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05758-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:54:29Z","timestamp":1769439269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05758-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5758"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05758-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study was a systematic review and meta-analysis based on previously published studies and de-identified, publicly available datasets (e.g., MIMIC-IV). For all included studies, the original investigators confirmed that appropriate ethical approvals and informed consent were obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}